GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abionyx Pharma (XPAR:ABNX) » Definitions » Float Percentage Of Total Shares Outstanding

Abionyx Pharma (XPAR:ABNX) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 18, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Abionyx Pharma Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Abionyx Pharma's float shares is 0.00 Mil. Abionyx Pharma's total shares outstanding is 32.20 Mil. Abionyx Pharma's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Abionyx Pharma's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Abionyx Pharma's Institutional Ownership is 0.03%.

Abionyx Pharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Abionyx Pharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/32.20
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abionyx Pharma (XPAR:ABNX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abionyx Pharma (XPAR:ABNX) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XPAR:ALACT XPAR:ALGEN XPAR:GNRO XPAR:ALCLS XPAR:PHXM XPAR:ALVIO XPAR:ALDVI XPAR:SIGHT XPAR:ALCOX XPAR:POXEL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
609:Germany
Address
33-43 Avenue Georges Pompidou-Bat D2, Balma, FRA, 31130
Website
https://www.abionyx.com
Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.

Abionyx Pharma (XPAR:ABNX) Headlines

No Headlines